ONCIN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Oncoinvent ASA engages in the development of cancer treatment products. It develops radiopharmaceutical products across a variety of solid cancers. The company was founded by Tina Bjornlund Bonsdorff, Oyvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ONCIN has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company